Biotage (www.biotage.com) and McMaster University agreed to create a a new chemistry platform. Biotage will provide funding and instruments, including an Initiator microwave synthesizer, SP4 flash purification system, and V10 Evaporator.
The McMaster Institute of Applied Radiation Sciences (McIARS) will apply funding and equipment to speed the development of novel molecular imaging agents for PET and SPECT and radiotherapy agents for treatment applications.
“This partnership brings together cutting edge synthesis and purification tools with radiopharmaceutical research, which spans basic science, to the development and testing of novel imaging and therapy agents,” says John F. Valliant, associate professor of chemistry and medical physics and acting director of McIARS.
“The new platform technologies will facilitate the process of producing tracers and therapeutics and it will be particularly useful for developing radiolabeled analogues of new drug candidates.”